Hepion Pharmaceuticals

+$0.0008 (+0.11%) Today
-$0.0457 (-6.13%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell HEPA and other ETFs, options, and stocks.

About HEPA

Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases. It focuses on the development of its product candidate CRV431, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease.

CEO
Robert T. Foster
Employees
20
Headquarters
Edison, New Jersey
Founded
2013

HEPA Key Statistics

Market cap
56.85M
Price-Earnings ratio
—
Dividend yield
—
Average volume
339.64K
High today
$0.78
Low today
$0.72
Open price
$0.75
Volume
162.26K
52 Week high
$2.32
52 Week low
$0.6101

HEPA Earnings

-$0.69
-$0.46
-$0.22
$0.01
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
Expected May 31, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure